Glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in neonates is associated with acute hemolytic episodes and severe hyperbilirubinemia with the potentially devastating complication of bilirubin encephalopathy. 1, 2 As a trigger of hemolysis may not always be identified and hematological changes such as decreasing hemoglobin (Hb) or hematocrit (Hct) values or increasing reticulocyte count are not consistently found, 3, 4 a misconception has arisen that the sudden increase in plasma total bilirubin (PTB) may not be due to hemolysis.
Although the total bilirubin concentration is used as an indication for the need to perform exchange transfusion the PTB value in and of itself is actually a poor predictor of bilirubin induced neurological damage (BIND). A more sensitive index is that of unbound bilirubin. 5, 6 In this report of a G-6-PD deficient premature neonate we demonstrate the development of severe hemolysis, confirmed by a high blood carboxyhemoglobin (COHb) level, but in the absence of changes in Hb, Hct and reticulocyte values. Extreme hyperbilirubinemia was accompanied by the presence of unbound bilirubin in the serum.
Case report
A 35-week gestation, 2.4 kg birth weight male infant was born in April 2006, to a Sephardic Jewish mother. The hospital course was uneventful except for moderate hyperbilirubinemia (peak PTB 14.0 mg dl À1 ), which was treated with phototherapy. The infant was discharged 7 days after birth. PTB at the time of discharge was 10.7 mg dl À1 and had been stable without phototherapy. The infant was fed breast milk with supplemental formula.
The day following discharge the parents cleaned their home using several commercial cleansing agents. That evening the baby began to look yellow. A PTB determined at a local laboratory the next morning was 28 mg dl À1 . On arrival at our NICU a few hours later (age 9 days) the baby had become golden orange in color. Neurological examination was normal and there was no clinical evidence of bilirubin encephalopathy. PTB concentration was 33 mg dl À1 (confirmed on repeat examination). An umbilical venous catheter was inserted following dissection of the umbilical stump. Double volume exchange transfusion was commenced within 1½ h of readmission and performed via this catheter. The PTB concentration following the exchange transfusion was 13.0 mg dl À1 . This rebounded under phototherapy to 20.0 mg dl À1 , and then gradually decreased over the next few days. The newborn remained neurologically intact and subsequent development has been normal. Auditory evaluation by brainstem auditory evoked response was normal. Because of the good outcome, MRI studies were not performed.
Laboratory methods PTB was measured routinely in the hospital's clinical biochemistry laboratory by a direct spectrophotometric method using centrifuged, heparinized capillary tube samples (Wako BilirubinTester, Wako Pure Chemical Industries Ltd, Osaka, Japan).
G-6-PD evaluation was performed using a qualitative, fluorescent commercial screening kit (Qualitative, visual fluorescence screening procedure in blood, procedure no. 202, produced by Sigma Diagnostics, St Louis, MO, USA). The fluorescent test is the screening method preferred by the World Health Organization, 7 is precise in male hemizygotes 8 and has been shown to be accurate in male newborns. 9 Serum albumin was measured routinely by an automated analyzer (Vitros 5,1, Ortho-Clinical Diagnostics Inc., Rochester, NY, USA).
Special investigations
From the first aliquot of blood removed during the exchange transfusion, blood for COHb determination (a sensitive and accurate index of heme catabolism) was collected into customprepared capillary tubes containing heparin and saponin, as previously described 10, 11 and stored at À18 1C until the thawed samples were transported on ice to Stanford University for analysis. COHb was determined by a gas chromatographic method, and its concentrations expressed as a percentage of total hemoglobin, which itself was quantified by the cyanmethemoglobin method, both as previously described. 10, 11 The principle of the COHb test is that, for every molecule of heme catabolized by the enzyme heme oxygenase to biliverdin (and subsequently bilirubin) equimolar quantities of carbon monoxide are produced. Accurate measurement of CO production, either as COHb or as end tidal CO, therefore provides an accurate index of the rate of heme catabolism. 12 Since ambient air for determination of its CO content was not sampled at the time of the exchange transfusion, the COHb result could not be corrected for inspired CO. However, the CO concentration in these nurseries has previously been shown to be low (0.5-1.5 ppm) and any expected correction would have been minimal with little clinical significance.
From this same blood sample serum was separated and stored at À70 1C pending analysis at Shaare Zedek Medical Center for total bilirubin and unbound bilirubin. Free bilirubin was determined by a technique for measuring the unconjugated fraction of the unbound bilirubin concentration in plasma by combining the peroxidase method for determining unbound bilirubin with a diazo method for measuring conjugated and unconjugated bilirubin, as previously described. 13 Laboratory results G-6-PD testing revealed lack of fluorescence, indicating an enzyme deficient state. Blood count results, summarized in Table 1 , demonstrated that there was very little change in Hb or Hct values or in reticulocyte count from the birth hospitalization until readmission. Results of COHb testing, total bilirubin, unbound bilirubin and serum albumin concentrations appear in Table 2 . Previously reported COHb results are included for reference. As will be noted, the COHb value at the beginning of the exchange transfusion was several fold that of the reported normal, indicating a high rate of heme catabolism. Upon completion of the exchange, the COHb value had decreased to that which would be expected in a normal newborn. Unbound bilirubin was detected in the preexchange transfusion serum sample.
Discussion
Because of the similarity to favism, acute hemolysis is usually implicated in the etiology of acute, extreme hyperbilirubinemia in G-6-PD deficient neonates. COHb studies in the present case as well as in those previously reported 16, 17 confirm that hemolysis is a major factor in the production of the icterus. The reason that even a moderate degree of hemolysis may result in extreme hyperbilirubinemia may be due to diminished bilirubin conjugation found in G-6-PD deficient neonates compared with G-6-PD adequate controls. 18 Any factor further diminishing bilirubin conjugation, such as (TA) 7 promoter polymorphism associated with Gilbert syndrome 19 or prematurity, 15 may even further compromise the equilibrium. A moderate degree of hemolysis may release bilirubin into the blood stream without significantly lowering the Hb or Hct value and the rapid nature of the process may not allow for a reticulocyte response. However, in the current case, the degree of hemolysis was several fold than normally encountered in G-6-PD deficient neonates ( Table 2 ). The reason 2.5
Abbreviations: COHbc, carboxyhemoglobin; G-6-PD, Glucose-6-phosphate dehydrogenase; Hb, hemoglobin. Previously reported COHb values corrected for ambient CO (COHbc) from this nursery are presented for reference.
for the remarkable dissociation between the severity of hyperbilirubinemia and the absence of anemia is not clear but this phenomenon is a well known feature of the neonatal manifestations of G-6-PD deficiency. 20 The unique feature of our case is that the COHb study documented severe hemolysis in the presence of extreme hyperbilirubinemia but absence of anemia.
The etiology of the hemolysis in the present case is not clear. Possibly the chemical cleaning agents used in the family's home served as triggers for hemolysis. As severe hyperbilirubinemia did not recur following the exchange transfusion, the lowered COHb value at the end of the exchange most likely indicated that the hemolytic process had been terminated.
Although we did detect unbound bilirubin in the pre-exchange sample, the infant remained neurologically unscathed. The value of unbound bilirubin which we documented (1.2 mg dl À1 ) would probably be insufficient to cause kernicterus in term infants, but may be associated with auditory nerve dysfunction. 6, 21, 22 However, even at lower concentrations of unbound bilirubin (0.5 mg dl À1 ), bilirubin induced auditory brainstem response (ABR) abnormalities have been noted in premature infants 23 and the unbound bilirubin value we documented is within the range which may be associated with kernicterus in these newborns (1.0-1.5 mg dl À1 ). 24 Ahlfors and Herbsman 6 suggest a much higher cut-off point (1.3 mg dl
À1
per kilogram, up to a maximum of 4 mg dl
), as the level of unbound bilirubin at which exchange transfusion should be considered. Indeed, the unbound bilirubin value was actually lower than what would be expected from similar neonatal accounts. For example, of eight newborns reported 6 with total bilirubin values >28 mg dl À1 (mean 30.5 ± 2.2 mg dl À1 ), the mean unbound bilirubin was 3.2±2.0 mg dl À1 . Therefore, despite the very high total bilirubin concentration, the level of unbound bilirubin in our late-preterm infant may not have been sufficient to pose a threat to the infant. The relatively low unbound bilirubin concentration in our infant may have due to the late onset of the severe hyperbilirubinemia (9 days), possibly resulting in improved bilirubin/albumin binding. The low unbound bilirubin value may explain the subsequently normal hearing evaluation and absence of signs of BIND, despite the very high PTB concentration. The relatively short period of hyperbilirubinemia and the speed with which the blood for transfusion was prepared and the transfusion commenced may have been additional factors contributing to the good outcome.
In conclusion, the infant that we report clearly had increased hemolysis despite the absence of hematological changes reflective of a hemolytic process. These observations support the concept that the extreme hyperbilirubinemia in G-6-PD deficient neonates is hemolytic in nature, thereby adding to the risk of BIND. 25 Exchange transfusion may not only lower the PTB but may attenuate the hemolytic process as well, presumably by removing chemical offenders from the body.
